An update on C-reactive protein for intensivists

Anaesthesia and Intensive Care

Volumn 37, Issue 2, 2009, Pages 234-241

  Ho, K M ^a,b   Lipman, J ^a,c,d  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Infection; Inflammatory markers; Inflammatory response; Outcomes; Predictor; Prognostic factor

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACUTE DISEASE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CRITICALLY ILL PATIENT; DISEASE MARKER; HUMAN; INFLAMMATION; INTENSIVE CARE; MEDICAL SPECIALIST; MYCOSIS; NONHUMAN; PATHOGENESIS; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TREATMENT RESPONSE; VIRUS INFECTION; BLOOD; IMMUNE SYSTEM; INTENSIVE CARE UNIT; METABOLISM; PHYSIOLOGY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTENSIVE CARE UNITS; LIPOPROTEINS, LDL; PROGNOSIS;

EID: 65549144770     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0903700217     Document Type: Review

References (79)

1. Tillet WS, Francis T Jr. Serologic reactions in pneumonia with a nonprotein fraction from Pneumococcus. J Exp Med 1930; 52:561-571.
2. Kyr M, Fedora M, Elbl L, Kugan N, Michalek J. Modeling effect of the septic condition and trauma on C-reactive protein levels in children with sepsis: a retrospective study. Crit Care 2007; 11:R70. (Pubitemid 47215441)
3. Póvoa P. Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Curr Opin Infect Dis 2008; 21:157-162.
4. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007; 11:R38. (Pubitemid 46629292)
5. Castelli GP, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 2006; 72:69-80. (Pubitemid 43230810)
6. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003. (Pubitemid 43982479)
7. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001; 154:681-689. (Pubitemid 32232166)
8. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006; 296:2703-2711.
9. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004; 279:48487-48490. (Pubitemid 39625721)
10. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004; 44:6-11.
11. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805-1812. (Pubitemid 38057722)
12. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981; 117:13-23. (Pubitemid 12228482)
13. Meier-Ewert HK, Ridker PM, Rifal N, Price N, Dinges DF, Mullington JM. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001; 47:426-430. (Pubitemid 32222455)
14. Wester AL, Blaasaas KG, Wyller TB. Is the concentration of C-reactive protein in bacteraemia associated with age? Immun Ageing 2008; 5:8.
15. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288:980-987.
16. Sierra R, Rello J, Bailén MA, Benítez E, Gordillo A, León C et al. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med 2004; 30:2038-2045. (Pubitemid 40022319)
17. Offidani M, Corvatta L, Malerba L, Piersantelli MN, Manso E, Leoni P. Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignancies. Support Care Cancer 2006; 14:874-877. (Pubitemid 44061001)
18. Wang YH, Lin AS, Chao TY, Lu SN, Liu JW, Chen SS et al. A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan. Intensive Care Med 2004; 30:1228-1231. (Pubitemid 38833382)
19. Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles E, Jessop JD. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000; 43:1473-1477. (Pubitemid 30452464)
20. Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease results from a prospective population-based study. Gut 2008; 57:1518-1523.
21. Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 2003; 29:1384-1389. (Pubitemid 37041172)
22. Schütte K, Malfertheiner P. Markers for predicting severity and progression of acute pancreatitis. Best Pract Res Clin Gastroenterol 2008; 22:75-90.
23. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006; 10:R1. (Pubitemid 47079170)
24. Herishanu Y, Perry C, Braunstein R, Metser U, Goor O, Rogowski O et al. Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma. Eur J Haematol 2007; 79:150-154. (Pubitemid 47063268)
25. McKeown DJ, Brown DJ, Kelly A, Wallace AM, McMillan DC. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer 2004; 91:1993-1995. (Pubitemid 40128764)
26. Williams RC Jr, Harmon ME, Burlingame R, Du Clos TW. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 2005; 32:454-461. (Pubitemid 40381415)
27. leDoux M, Braslow K, Brown TM. C-reactive protein and serotonin syndrome. Am J Psychiatry 2004; 161:1499.
28. Izumi S, Hughes RD, Langley PG, Pernambuco JR, Williams R. Extent of the acute phase response in fulminant hepatic failure. Gut 1994; 35:982-986. (Pubitemid 24202731)
29. Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005; 146:347-351. (Pubitemid 41712021)
30. Delgado AF, Okay TS, Leone C, Nichols B, Del Negro GM, Vaz FA. Hospital malnutrition and inflammatory response in critically ill children and adolescents admitted to a tertiary intensive care unit. Clinics 2008; 63:357-362.
31. Williamson L, Bowness P, Mowat A, Ostman-Smith I. Lesson of the week: difficulties in diagnosing acute rheumatic fever-arthritis may be short lived and carditis silent. BMJ 2000; 320:362-365. (Pubitemid 30081682)
32. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis 2004; 36:424-427. (Pubitemid 39089190)
33. Halonen J, Halonen P, Järvinen O, Taskinen P, Auvinen T, Tarkka M et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 2007; 297:1562-1567. (Pubitemid 46588369)
34. Pihusch M, Pihusch R, Fraunberger P, Pihusch V, Andreesen R, Kolb HJ et al. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 2006; 76:93-101.
35. Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004; 50:581-588. (Pubitemid 38198843)
36. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002; 359:1187-1193. (Pubitemid 34304258)
37. Kline JA, Zeitouni R, Marchick MR, Hernandez-Nino J, Rose GA. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J 2008; 156:308-314.
38. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001; 32:917-924. (Pubitemid 32285161)
39. Banu NS, Gaze DC, Bruce H, Collinson PO, Belli AM, Manyonda IT. Markers of muscle ischemia, necrosis, and inflammation following uterine artery embolization in the treatment of symptomatic uterine fibroids. Am J Obstet Gynecol 2007; 196:213. (Pubitemid 46341209)
40. Bargues L, Chancerelle Y, Catineau J, Jault P, Carsin H. Evaluation of serum procalcitonin concentration in the ICU following severe burn. Burns 2007; 33:860-864. (Pubitemid 47374355)
41. Herishanu Y, Perry C, Braunstein R, Metser U, Goor O, Rogowski O et al. Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma. Eur J Haematol 2007; 79:150-154. (Pubitemid 47063268)
42. El-Maghraby SM, Moneer MM, Ismail MM, Shalaby LM, El-Mahallawy HA. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. J Pediatr Hematol oncol 2007; 29:131-136. (Pubitemid 46673396)
43. McKeown DJ, Brown DJ, Kelly A, Wallace AM, McMillan DC. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer 2004; 91:1993-1995. (Pubitemid 40128764)
44. Nakanishi H, Araki N, Kudawara I, Kuratsu S, Matsumine A, Mano M et al. Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma. Int J Cancer 2002; 99:167-170. (Pubitemid 34309471)
45. Flores JM, Jiménez PI, Rincón D, Márquez J, Navarro H, Muñoz A et al. C reactive protein as marker of infection among patients with severe closed trauma. Enferm Infecc Microbiol Clin 2001; 19:61-65. (Pubitemid 33675676)
46. Persson L, Engervall P, Magnuson A, Vikerfors T, Söderquist B, Hansson LO et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004; 36:365-371. (Pubitemid 38967694)
47. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P et al. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 2006; 10:R63. (Pubitemid 47079868)
48. Martini A, Gottin L, Mélot C, Vincent JL. A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unit. J Infect 2008; 56:313-318.
49. Schmit X, Vincent JL. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008; 36:213-219.
50. Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JY. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002; 30:529-535. (Pubitemid 34214612)
51. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Mélot C et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123:2043-2049. (Pubitemid 36706731)
52. Ho KM, Dobb GJ, Lee KY, Towler SC, Webb SA. C-reactive protein concentration as a predictor of intensive care unit readmission: a nested case-control study. J Crit Care 2006; 21:259-265. (Pubitemid 44380341)
53. Ho KM, Lee KY, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 2008; 34:481-487.
54. Koegelenberg CF, Doubell AF, orth H, Reuter H. Infective endocarditis: improving the diagnostic yield. Cardiovasc J S Afr 2004; 15:14-20. (Pubitemid 38418417)
55. Stachon A, Becker A, Holland-Letz T, Friese J, Kempf R, Krieg M. Estimation of the mortality risk of surgical intensive care patients based on routine laboratory parameters. Eur Surg Res 2008; 40:263-272.
56. Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR. Prognostic utility of postoperative C-reactive protein for post-hepatectomy liver failure. Arch Surg 2008; 143:247-253.
57. Dornbusch HJ, Strenger V, Sovinz P, Lackner H, Schwinger W, Kerbl R et al. Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders. Support Care Cancer 2008; 16:1035-1040.
58. Vandijck DM, Hoste EA, Blot SI, Depuydt PO, Peleman RA, Decruyenaere JM. Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infect Dis 2007; 7:106.
59. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329:168-169.
60. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003; 96:793-807. (Pubitemid 37369294)
61. Vogt B, Führnrohr B, Müller R, Sheriff A. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 2007; 40:295-298. (Pubitemid 46845524)
62. Baidoshvili A, Nijmeijer R, Lagrand WK, Hack CE, Niessen HW. Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis. J Clin Pathol 2002; 55:152-153. (Pubitemid 34123921)
63. Nijmeijer R, Lagrand WK, Lubbers YT, Visser CA, Meijer CJ, Niessen HW et al. C-reactive protein activates complement in infarcted human myocardium. Am J Pathol 2003; 163:269-275. (Pubitemid 36759611)
64. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A et al. Autoantibodies against protective molecules - C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007; 1108:227-239. (Pubitemid 47528736)
65. Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE et al. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis 2008; 201:318-325.
66. Verma S, Szmitko PE, Yeh ET. C-reactive protein: structure affects function. Circulation 2004; 109:1914-1917. (Pubitemid 38544477)
67. Zouaoui Boudjeltia K, Piagnerelli M, Brohée D, Guillaume M, Cauchie P, Vincent JL et al. Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients? Thromb J 2004; 2:7.
68. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108:3006-3010. (Pubitemid 37553570)
69. Liu T, Li L, Korantzopoulos P, Goudevenos JA, Li G. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation. Am J Cardiol 2008; 101:1749-1752.
70. Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 2002; 4:331-336.
71. Ferrante G, Niccoli G, Biasucci LM, Liuzzo G, Burzotta F, Galiuto L et al. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med 2008; 9:156-165.
72. Foussas SG, Zairis MN, Makrygiannis SS, Manousakis SJ, Anastassiadis FA, Apostolatos CS et al. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction. Heart 2007; 93:952-956. (Pubitemid 47122047)
73. Gölbasi Z, Uçar O, Keles T, Sahin A, Cagli K, Camsari A et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 2002; 4:593-595. (Pubitemid 35278511)
74. Owens CD, Ridker PM, Belkin M, Hamdan AD, Pomposelli F, Logerfo F et al. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg 2007; 45:2-9. (Pubitemid 46038651)
75. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005; 4:371-380. (Pubitemid 40720034)
76. D'Elia JA, Weinrauch LA, Gleason RE, Lipinska I, Lipinski B, Lee AT et al. Risk factors for thromboembolic events in renal failure. Int J Cardiol 2005; 101:19-25. (Pubitemid 40614731)
77. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004; 15:3184-3191. (Pubitemid 39578851)
78. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007; 56:872-878.
79. Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 2008; Aug 15 :[Epub ahead of print].